UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study

Molecular cancer, 2022-01, Vol.21 (1), p.21-21, Article 21

2022

Link zum Volltext

Verfügbarkeit prüfen

Metformin Inhibits Castration-induced EMT in Prostate Cancer by Repressing COX2/PGE2/STAT3 Axis

Cancer letters, 2017-03, Vol.389, p.23-32

2017

Link zum Volltext

Verfügbarkeit prüfen

Twist: a molecular target in cancer therapeutics

Tumor biology, 2013-10, Vol.34 (5), p.2497-2506

2013

Link zum Volltext

Verfügbarkeit prüfen

Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration

Clinical cancer research, 2018-11, Vol.24 (22), p.5622-5634

2018

Link zum Volltext

Verfügbarkeit prüfen

Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway

Pharmacological research, 2019-06, Vol.144, p.79-89

2019

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Regulation and dysfunction of CSK and CHK

Frontiers in cell and developmental biology, 2023-07, Vol.11, p.1254961-1254961

2023

Link zum Volltext

Verfügbarkeit prüfen

The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36

Nature, 2006-07, Vol.442 (7100), p.312-316

2006

Link zum Volltext

Verfügbarkeit prüfen

Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT

Cell death & disease, 2017-08, Vol.8 (8), p.e3007-e3007

2017

Link zum Volltext

Verfügbarkeit prüfen

Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling

Oncogene, 2021-03, Vol.40 (11), p.1974-1987

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeted therapies for advanced non-small cell lung cancer

Oncotarget, 2018-12, Vol.9 (101), p.37589-37607

2018

Link zum Volltext

Verfügbarkeit prüfen

Regulation, targets and functions of CSK

Frontiers in cell and developmental biology, 2023-06, Vol.11, p.1206539-1206539

2023

Link zum Volltext

Verfügbarkeit prüfen

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma

Frontiers in endocrinology (Lausanne), 2020-11, Vol.11, p.586857-586857

2020

Link zum Volltext

Verfügbarkeit prüfen

Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor

The Prostate, 2015-08, Vol.75 (11), p.1187-1196

2015

Link zum Volltext

Verfügbarkeit prüfen

MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway

Immunology letters, 2016-04, Vol.172, p.1-10

2016

Link zum Volltext

Verfügbarkeit prüfen

Correction: Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling

Oncogene, 2021-08, Vol.40 (34), p.5356-5356

2021

Link zum Volltext

Verfügbarkeit prüfen

LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT

Frontiers in oncology, 2020-07, Vol.10, p.1234-1234

2020

Link zum Volltext

Verfügbarkeit prüfen

Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis

Oncotarget, 2016-05, Vol.7 (19), p.28235-28246

2016

Link zum Volltext

Verfügbarkeit prüfen

Regulation, targets and functions of CHK

Frontiers in cell and developmental biology, 2022-12, Vol.10, p.1068952-1068952

2022

Link zum Volltext

Verfügbarkeit prüfen

Incidence of lung cancer among healthcare workers in Hunan Province and analysis of related risk factors

Frontiers in public health, 2023, Vol.11, p.1280316-1280316

2023

Link zum Volltext

Verfügbarkeit prüfen

The Many Faces of MTA3 Protein in Normal Development and Cancers

Current protein & peptide science, 2016-01, Vol.17 (8), p.726

2016

Link zum Volltext

Verfügbarkeit prüfen

Genotype-phenotype correlation in patients with 21-hydroxylase deficiency

Frontiers in endocrinology (Lausanne), 2023-03, Vol.14, p.1095719-1095719

2023

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance

Frontiers in pharmacology, 2022-04, Vol.13, p.838171-838171

2022

Link zum Volltext

Verfügbarkeit prüfen

Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations

BMC endocrine disorders, 2023-04, Vol.23 (1), p.77-77, Article 77

2023

Link zum Volltext

Verfügbarkeit prüfen

MTA3-SOX2 Module Regulates Cancer Stemness and Contributes to Clinical Outcomes of Tongue Carcinoma

Frontiers in oncology, 2019-08, Vol.9, p.816-816

2019

Link zum Volltext

Verfügbarkeit prüfen

The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment

Journal of xenobiotics, 2021-02, Vol.11 (1), p.16-32

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Englisch
(110)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(69)
Humans
(48)
Oncology
(32)
Animals
(23)
Male
(22)
Cell Line, Tumor
(17)
Female
(17)
Cell Biology
(16)
Prognosis
(12)
Prostate Cancer
(12)
Mice
(11)
Cancer
(10)
Biochemistry & Molecular Biology
(9)
Gene Expression Regulation, Neoplastic
(9)
Middle Aged
(9)
Endocrinology & Metabolism
(8)
Esophageal Cancer
(8)
Signal Transduction
(8)
Adult
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study

Metformin Inhibits Castration-induced EMT in Prostate Cancer by Repressing COX2/PGE2/STAT3 Axis

Twist: a molecular target in cancer therapeutics

Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration

Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway

Editorial: Regulation and dysfunction of CSK and CHK

The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36

Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT

Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling

Targeted therapies for advanced non-small cell lung cancer

Regulation, targets and functions of CSK

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma

Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor

MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway

Correction: Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling

LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT

Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis

Regulation, targets and functions of CHK

Incidence of lung cancer among healthcare workers in Hunan Province and analysis of related risk factors

The Many Faces of MTA3 Protein in Normal Development and Cancers

Genotype-phenotype correlation in patients with 21-hydroxylase deficiency

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance

Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations

MTA3-SOX2 Module Regulates Cancer Stemness and Contributes to Clinical Outcomes of Tongue Carcinoma

The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment

Suchergebnisse filtern